Dihydromyricetin from Ampelopsis grossedentata inhibits melanogenesis through down-regulation of MAPK, PKA and PKC signaling pathways.

doi:10.1016/j.cbi.2016.08.023

Paper

Dihydromyricetin from Ampelopsis grossedentata inhibits melanogenesis through down-regulation of MAPK, PKA and PKC signaling pathways.

Published Oct 25, 2016 · Huey-Chun Huang, Chun-Chieh Liao, Chu-Chun Peng

Chemico-biological interactions

Q1 SJR score

37

Citations

2

Influential Citations

Full textSemantic Scholar

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

In Vitro Study

Study Snapshot

Dihydromyricetin from Ampelopsis grossedentata inhibits melanogenesis and exhibits antioxidant properties, making it a potential candidate for developing depigmentation skin care products.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Dihydromyricetin from Ampelopsis grossedentata inhibits melanogenesis through down-regulation of MAPK, PKA and PKC signaling pathways.

References

Citations